Drug intelligence / Profile preview

SNX-482

Development stage
Unknown
Modality
Peptides, Recombinant Proteins and Enzymes
Administration
Intracerebroventricular, Intrathecal
01

Overview

SNX-482 is a peptide toxin derived from the venom of the African tarantula *Hysterocrates gigas*. It functions as a potent and selective inhibitor of voltage-gated calcium channels, specifically the CaV2.3 subtype (R-type calcium channels), with an IC50 of 30 nM. Additionally, it exhibits potent inhibitory effects on A-type potassium currents, particularly Kv4.3 channels (IC50 < 3 nM), and to a lesser extent, Kv4.2 channels. Its mechanism of action involves binding to the voltage-sensing domains of these ion channels, thereby modulating their activation and gating kinetics. SNX-482 has been utilized as a research tool to investigate the roles of these specific ion channels in various physiological and pathological processes, including its antinociceptive properties observed in models of chronic neuropathic pain.

02

Targets

CACNA1E (Voltage-dependent R-type calcium channel subunit alpha-1E)CACNA1C (Voltage-dependent L-type calcium channel subunit alpha-1C)KCND3 (Potassium voltage-gated channel subfamily D member 3 with KChIP2 coexpression complex)

Beyond the preview

Go deeper on SNX-482.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SNX-482.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call